Original Source(s)
Related Content
Privosegtor Receives Breakthrough Drug Designation
In a phase 2 trial, the drug showed functional and structural signals in optic neuritis.
January 6, 2026
-
2 min
The Retina: A Window on Neurodegeneration
New evidence links Chlamydia pneumoniae to retinal inflammation patterns associated with neurodegeneration
March 9, 2026
-
7 min